Oncolytic Vaccinia Virus Armed with GM-CSF and IL-7 Enhances Antitumor Immunity in Pancreatic Cancer

Oncolytic Vaccinia Virus Armed with GM-CSF and IL-7 Enhances Antitumor Immunity in Pancreatic Cancer

<b>Objectives:</b> Pancreatic cancer remains a therapeutic challenge due to its immunosuppressive microenvironment and treatment resistance. This study aimed to develop a novel recombinant oncolytic vaccinia virus (VVL-GL7) co-expressing granulocyte-macrophage colony-stimulating factor (...

Full description

Saved in:

Bibliographic Details
Main Authors:	Wenyi Yan, Yujing Xuan, Ruimin Wang, Ziyan Huan, Yu Guo, Huilin Dun, Lihua Xu, Ruxia Han, Xianlei Sun, Lingling Si, Nicholas Robert Lemoine, Yaohe Wang, Pengju Wang
Format:	Article
Language:	English
Published:	MDPI AG 2025-04-01
Series:	Biomedicines
Subjects:	oncolytic virus vaccinia virus GM-CSF IL-7 pancreatic cancer
Online Access:	https://www.mdpi.com/2227-9059/13/4/882
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

GM-CSF and IL-21-armed oncolytic vaccinia virus significantly enhances anti-tumor activity and synergizes with anti-PD1 immunotherapy in pancreatic cancer
by: Yujing Xuan, et al.
Published: (2025-01-01)

Dose Considerations for Vaccinia Oncolytic Virus Based on Retrospective Reanalysis of Early and Late Clinical Trials
by: Mefotse Saha Cyrelle Ornella, et al.
Published: (2024-09-01)

Advances of oncolytic vaccinia viruses armed with interleukin in tumor therapy
by: Mingyong Zha, et al.
Published: (2025-05-01)

A novel oncolytic Vaccinia virus armed with IL-12 augments antitumor immune responses leading to durable regression in murine models of lung cancer
by: Lijuan Chen, et al.
Published: (2025-01-01)

Deletion of F4L (ribonucleotide reductase) in vaccinia virus produces a selective oncolytic virus and promotes anti‐tumor immunity with superior safety in bladder cancer models
by: Kyle G Potts, et al.
Published: (2017-03-01)

Oncolytic adenovirus inhibits TNBC tumor growth/metastasis in mice by targeting TGFB and overexpressing GM-CSF
by: Nguyễn Thị Thanh Nhàn, et al.
Published: (2025-03-01)

Oncolytic Viruses in Ovarian Cancer: Where Do We Stand? A Narrative Review
by: Fulvio Borella, et al.
Published: (2025-02-01)

Expression of GPX4 by oncolytic vaccinia virus can significantly enhance CD8+T cell function and its impact against pancreatic ductal adenocarcinoma
by: Wei Wei, et al.
Published: (2024-12-01)

Challenges and strategies toward oncolytic virotherapy for leptomeningeal metastasis
by: Jia-Li Zhao, et al.
Published: (2024-11-01)

A model of the artificial metastasis of human epidermoid carcinoma A431 in nude mice for examination of the oncolytic activity of vaccinia virus
by: G. V. Kochneva, et al.
Published: (2015-12-01)

A vaccinia virus renaissance<subtitle>New vaccine and immunotherapeutic uses after smallpox eradication</subtitle>
by: Paulo H. Verardi, et al.
Published: (2012-07-01)

Sophora flavescens-derived extracellular vesicles loaded with oncolytic vaccinia virus/IR1061 for NIR-II photoacoustic imaging guided multimodal treatment of diffuse large B-cell lymphoma
by: Lichen Ji, et al.
Published: (2025-10-01)

Oncolytic vaccinia virus harboring CLEC2A gene enhances viral replication and antitumor efficacy
by: Chunqing Gao, et al.
Published: (2024-09-01)

The effect of GM-CSF and predictors of treatment outcome in pediatric septic shock patients
by: Zhen-Hao Yu, et al.
Published: (2025-02-01)

Comparative evaluation of immunomodulatory cytokines for oncolytic therapy based on a high-efficient platform for oHSV1 reconstruction
by: Yingzheng Gao, et al.
Published: (2025-05-01)

Temporal expression classes and functions of vaccinia virus and mpox (monkeypox) virus genes
by: Yining Deng, et al.
Published: (2025-04-01)

Colonic growth factors (G-CSF, GM-CSF) and chemokines (MCP-1, MIP-1β) in severe ulcerative colitis
by: Yevgeny A. Konovich, et al.
Published: (2018-08-01)

Reduced plasma levels of GM-CSF is a common feature of Schistosoma mansoni-infected school-aged children
by: Severin Donald Kamdem, et al.
Published: (2025-02-01)

Isolation and Characterization of E8 Monoclonal Antibodies from Donors Vaccinated with Recombinant Vaccinia Vaccine with Efficient Neutralization of Authentic Monkeypox Virus
by: Yutao Shi, et al.
Published: (2025-04-01)

Advances in Oncolytic Viral Therapy in Melanoma: A Comprehensive Review
by: Ayushi Garg, et al.
Published: (2025-07-01)

Vaccinia virus modulates the redox environment by inhibiting reactive oxygen and nitrogen species with increased activity of endogenous antioxidant enzymes
by: Marília Bueno da Silva Menegatto, et al.
Published: (2025-08-01)

Narciclasine inhibits vaccinia virus infection by activating the RhoA signaling pathway
by: Ting Xu, et al.
Published: (2024-12-01)

Investigation of the Antiviral Activity of Experimental Samples Obtained from the Grass and Roots of Alchemilla vulgaris L. Against Vaccinia Virus and Ectromelia Virus
by: N. A. Mazurkova, et al.
Published: (2019-11-01)

Decreased PD-L1 contributes to preeclampsia by suppressing GM-CSF via the JAK2/STAT5 signal pathway
by: Yingying Tian, et al.
Published: (2025-01-01)

Role of GM-CSF in normalizing the effect of Uremic Toxins on Neutrophil Apoptosis and Function
by: Nariman Zahran, et al.
Published: (2014-08-01)

Translation of oncolytic viruses in sarcoma
by: Steven I. Robinson, et al.
Published: (2024-09-01)

Exogenous GM-CSF therapy for autoimmune pulmonary alveolar proteinosis: a systematic literature review
by: Wushu Chen, et al.
Published: (2025-05-01)

GM-CSF potentiates macrophages to retain an inflammatory feature from their circulating monocyte precursors in rheumatoid arthritis
by: Jianing Chen, et al.
Published: (2025-08-01)

Ad6-Based GM-CSF Expressing Vector Displays Oncolytic and Immunostimulatory Effects in an Immunocompetent Syrian Hamster Model of Cholangiocarcinoma
by: Daria S. Zabelina, et al.
Published: (2025-01-01)

Accelerating infectious wound healing through bacterial cellulose/ag composite film enriched with GM-CSF
by: Bilin Zhang, et al.
Published: (2025-07-01)

Corrigendum: Exogenous GM-CSF therapy for autoimmune pulmonary alveolar proteinosis: a systematic literature review
by: Wushu Chen, et al.
Published: (2025-06-01)

Geographic Distribution of Vaccinia Virus, Diagnosis and Demographic Aspects of Affected Populations, Minas Gerais, Brazil, 2000–2023
by: Pedro H. B. e Silva, et al.
Published: (2024-12-01)

DIRECTED EVOLUTION OF AN ONCOLYTIC VESICULAR STOMATITIS VIRUS ADAPTED TO HUMAN MALIGNANT MENINGIOMA CELLS
by: Burak Gizem Göleş, et al.
Published: (2024-02-01)

Expression of 6 × his-hGM-CSF fusion gene in larvae of silkworm (Bombyx mori) using recombinant baculovirus
by: ZHU Li-cheng, et al.
Published: (2005-09-01)

Exploring the function and pathogenicity of Goatpox virus N1L gene using recombinant vaccinia virus Tiantan strain
by: Jialiang Xin, et al.
Published: (2025-07-01)

Vaccinia virus-regulated acute phase cytokine production in human fibroblasts, U937 cells and endothelium
by: H. Rokita, et al.
Published: (1998-01-01)

Specific Immune Responses and Oncolytic Effects Induced by EBV LMP2A-Armed Modified Ankara-Vaccinia Virus Vectored Vaccines in Nasopharyngeal Cancer
by: Liying Sun, et al.
Published: (2025-01-01)

Correlation between microneutralization test and a multiplexed immunoassay for evaluation of monkeypox and vaccinia virus antibodies before and after smallpox vaccination
by: Serena Marchi, et al.
Published: (2025-06-01)

Therapy gone viral: Exploring the use of oncolytic viruses in non-small cell lung cancer immunotherapy
by: Jemima Steele, et al.
Published: (2025-01-01)

Oncolytic Vesicular Stomatitis Virus: Optimisation Strategies for Anti-Cancer Therapies
by: Margarita Zinovieva, et al.
Published: (2024-10-01)